Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer

by Hideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, Ken-ichi Tabata, Shouko Komori, Akane Sekiguchi, Masaomi Ikeda, Shinji Kurosaka, Tetsuo Fujita, Masashi Kitano, Kazushige Hayakawa, Masatsugu Iwamura
Published 2016-04-01

Feasibility of definitive chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma: A retrospective study

by Akinori Watanabe, MD, Chikatoshi Katada, MD, PhD, Shouko Komori, MD, Hiromitsu Moriya, MD, PhD, Keishi Yamashita, MD, PhD, Hiroki Harada, MD, Mizutomo Azuma, MD, PhD, Yuki Kondo, MD, Yo Kubota, MD, Yasuaki Furue, MD, Natsuko Kawanishi, MD, Sakiko Yamane, MD, Takuya Wada, MD, Takafumi Yano, MD, Kenji Ishido, MD, PhD, Satoshi Tanabe, MD, PhD, Kazushige Hayakawa, MD, PhD, Wasaburo Koizumi, MD, PhD
Published 2018-07-01